Study participants and vaccination | Antibody against whole asexual stage antigens by C-IFA (Mean PPFC) | Antibody against GMZ2 by ELISA (Mean Ab titers) |
---|---|---|
 | Rho (95% CI) | Rho (95% CI) |
Antibody against stage V gametocytes by C-IFA (Mean PPFC) | ||
Adults | ||
 D0a | 0.39 (0.03, 0.66)* | 0.17 (−0.18, 0.48) |
 D84 (GMZ2) | 0.41 (−0.17, 0.78) | 0.44 (−0.13, 0.80) |
 D84 (Rabies) | 0.40 (−0.21, 0.79) | 0.54 (−0.03, 0.85) |
Children | ||
 D0a | 0.16 (−0.24, 0.51) | 0.28 (−0.11, 0.60) |
 D84 (GMZ2, 30 µg dose) | 0.02 (−0.62, 0.64) | −0.10 (−0.69, 0.57) |
 D84 (GMZ2, 100 µg dose) | 0.06 (−0.59, 0.67) | 0.22 (−0.48, 0.75) |
 D84 (Rabies) | −0.27 (−0.77, 0.44) | 0.22 (−0.48, 0.75) |